Four microbiome myths we still hear in clinic
Microbiome testing has moved quickly from research into routine clinical practice, and with that pace comes a fair amount of received wisdom that no longer holds up. Some of it is outdated, some of it was never quite right to begin with. Either way, it shapes how testing is offered, interpreted and explained to patients.
Here are four myths we still hear in clinic, and what the evidence actually says.
Myth 1: Microbiome testing is only relevant for patients presenting with GI symptoms
It is easy to file the microbiome under gut health and leave it there. But microbiome disruption is linked to metabolic, immune, neurological and skin health, and testing can offer additional clinical context well beyond GI symptoms.
For patients whose presentation does not point neatly at the gut, that wider lens is often where the value sits.
Myth 2: A short dietary intervention can meaningfully shift the microbiome
Diet does change the gut microbiome, but meaningful, sustained change takes time, and a brief intervention rarely delivers it.
Set realistic expectations with patients – a week of fermented foods will not remodel an ecosystem, and framing it that way with patients sets up a fairer view of what their efforts can achieve.
Myth 3: A healthy microbiome profile looks the same across patients
There is no single ‘ideal’ microbiome. Diversity, keystone species and functional capacity all vary between individuals, which means a result that looks unremarkable for one patient may be meaningful for another.
This is why personalised interpretation matters. Reading a profile against the person in front of you, rather than against a fixed template, is what turns data into clinical insight.
Myth 4: qPCR panels give you the full clinical picture
qPCR panels are useful, but they target a narrow set of predefined organisms. They tell you about the things they were designed to look for, and nothing about the rest of the community.
Whole-microbiome profiling captures the full community – bacteria, archaea fungi – giving you the resolution to see what targeted panels miss.
A note for your next patient conversation
If any of these myths sound familiar, they are worth revisiting. Whole-microbiome profiling gives you a fuller view of the ecosystem you are working with, and a stronger basis for the conversations that follow.
References
Asadi A, et al. Obesity and gut-microbiota-brain axis: a narrative review. J Clin Lab Anal. 2022;36(5):e24420. https://doi.org/10.1002/jcla.24420